oxazoles has been researched along with gdc 0449 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dismuke, T; Gershon, TR; Hwang, D; Kabanov, AV; Kagel, JR; Lim, C; Ramsey, JD; Rosen, EP; Sokolsky-Papkov PhD, M; Tikunov, A; Zamboni, W | 1 |
1 other study(ies) available for oxazoles and gdc 0449
Article | Year |
---|---|
Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity.
Topics: Anilides; Animals; Biological Availability; Central Nervous System; Cerebellar Neoplasms; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Medulloblastoma; Mice; Micelles; Nanoparticles; Oxazoles; Particle Size; Protein Binding; Pyridines; Serum Albumin | 2021 |